Proactive Investors - Run By Investors For Investors

Feedback appoints subsidiary CEO as new chief executive

Dr Tom Oakley is a qualified clinical radiologist who has previously served as director of NHS services at telemedicine firm, Synergix Health
Board room
Oakley became CEO of Feedback Medical in mid-February

Feedback PLC (LON:FDBK) has appointed the chief executive (CEO) of its operating subsidiary, Feedback Medical, as its own CEO with immediate effect.

Dr Tom Oakley, who became CEO of Feedback Medical in mid-February, is a qualified clinical radiologist who has previously served as director of NHS services at telemedicine firm Synergix Health, while he also founded Innovation Doctor, which explored the digital healthcare space.

READ:​ Feedback appoints Dr Tom Oakley as new chief executive of subsidiary

Feedback added that Dr Alastair Riddell, its current executive chairman, would resume the role of non-executive chairman which he occupied prior to June 2018.

Oakley said that he planned to complete a full review of the business “over the coming weeks” in order to “maximise Feedback's market position, identify growth areas and review new potential market areas within digital imaging”.

Feedback specialises in software used to analyse and manage medical imaging databases.

View full FDBK profile View Profile

Feedback PLC Timeline

Related Articles

MRI scan
February 22 2019
In February, the firm appointed Dr Tom Oakley, a qualified radiologist and former director of NHS services at telemedicine firm Synergix Health, as the new chief executive of its trading company Feedback Medical
Electrolyser
March 20 2019
ITM Power’s first-half results in January showed the hydrogen energy solutions provider has significantly strengthened its capability to deliver larger industrial scale projects
Turbine
May 15 2019
The multi-faceted energy company builds low-emission, clean-energy microturbine technology for consumer and commercial use globally

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use